Skip to main navigation Skip to search Skip to main content

Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis

  • SUNY Buffalo
  • University Hospital Centre Rijeka
  • SUNY Upstate Medical University
  • Brown University

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

PURPOSE: To determine to what extent T1- and T2-regional lesion volumes (RLVs) contribute to total and/or regional gray matter (GM) atrophy in multiple sclerosis (MS). METHODS: We studied 110 (67 relapsing-remitting and 43 secondary-progressive) MS patients. SABRE program was used to parcel the brain into 13 regions per hemisphere. Total and regional GM fractions (GMFs) were determined in each region to correct for intraregional size variability. Partial correlations were used to determine associations (holding the converse constant) between RLVs, GMF, and regional GMFs (P < .001 to avoid Type 1 error). RESULTS: Partial correlations between RLVs and regional GMFs (controlling for total GMF) for the total MS group were not significant for any of the 26 regions for T2, whereas they were significant for two of the 26 regions for T1. Partial correlations between RLVs and total GMF (controlling for regional GMF) for the total MS group were significant in 9 of 26 regions for T2 (largest r = right lateral inferior frontal, -.45) and 5 of 26 regions for T1 (largest r = right inferior parietal, -.45). CONCLUSIONS: Results suggest a model whereby a distinct generalized disease process accounts for GM atrophy better than regionally distinct Wallerian degeneration.

Original languageEnglish
Pages (from-to)210-218
Number of pages9
JournalJournal of Neuroimaging
Volume21
Issue number3
DOIs
StatePublished - Jul 2011

Keywords

  • Gray matter atrophy
  • Multiple sclerosis
  • Regional white matter lesions
  • Wallerian degeneration

Fingerprint

Dive into the research topics of 'Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis'. Together they form a unique fingerprint.

Cite this